Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 139 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1381 8.7 months Advanced NSCLC 5 Chemotherapy
Christie Hospital United Kingdom 7/2006
Treatment Details: Patients: This Phase III trial involved a total of 433 patients with advanced non-small-cell lung cancer. There were 295 men and 138 women. The median age was 63. Patients were divided in
 
1382 8.7 months Metastatic melanoma 5 Chemotherapy
Dana-Farber Cancer Institute United States 12/2008
Treatment Details: Patients: In this phase 3 study, patients with metastatic melanoma were divided into two separate treatment groups. Group 1 included 195 patients with a median age of 50.5 years and 75% ma
 
1383 8.6 months Metastatic melanoma 5 Biologic therapy
Sarah Cannon Research Institute United States 9/2010
Treatment Details: Patients: This phase II study involved 57 patients with metastatic melanoma. The median age was 70 years and 68% of patients were male. Treatment: Patients were administered a combinat
 
1384 8.6 months Newly diagnosed GBM 5 Biologic therapy
Chemotherapy
Radiation
Cleveland Clinic United States 12/2009
Treatment Details: Patients: This phase 2 study involved 27 patients with newly diagnosed glioblastoma multiforme. Their median age was 52 years old. Most (16) had received surgery for their brain tumor. T
 
1385 8.6 months Advanced NSCLC 4 Chemotherapy
University Hospital Sweden 11/2005
Treatment Details: Patients: This Phase III study involved a total of 325 patients. Patients were divided into two groups: Group A had 169 patients and Group B had 156 patients. The median age for patients i
 
1386 8.6 months Relapsed or refractory NSCLC 4 Chemotherapy
Wake Forest University United States 6/2005
Treatment Details: Patients: This Phase II study involved 52 patients with non-small-cell lung cancer (26 with adenocarcinoma). Twenty-seven patients were men, and twenty-five were women. The median age was
 
1387 8.6 months Metastatic malignant melanoma 4 Biologic therapy
Chemotherapy
Mayo Clinic Rochester United States 1/2013
Treatment Details: Patients: This phase 2 study involved 48 metastatic malignant melanoma patients with a median age of 60 years; 66% were male. Treatment: Patients were treated with the chemotherapy agen
 
1388 8.6 months Metastatic colorectal carcinoma 5 Biologic therapy
University of California, Los Angeles United States 4/2010
Treatment Details: Patients: This study involved metastatic colorectal cancer patients who were divided into two separate patient groups based on the level of the epidermal growth factor receptor (EGFR) prote
 
1389 8.6 months GBM 4 Chemotherapy
University of Heidelberg Germany 7/2012
Treatment Details: This study involved elderly patients with anaplastic astrocytoma or glioblastoma who were divided into two separate treatment groups. Group A had 195 patients with a median age of 72 years
 
1390 8.6 months Metastatic melanoma 4 Chemotherapy
Saint John's Health Center United States 1/2012
Treatment Details: Patients: This phase II study involved previously untreated metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 71 patients with a median
 
Page 139 of 187  | Previous Page  | Next Page